LAKE OSWEGO, Ore. & BERLIN--(BUSINESS WIRE)--BIOTRONIK, a leading manufacturer of implantable cardiac devices and pioneer of wireless remote monitoring technologies, announced today the US market ...

With BIOTRONIK Home Monitoring ® you can significantly reduce the follow-up burden, and it provides you by the same time with early detection of clinically relevant events. To sum up: it improves the ...

Biotronik announced today that it received FDA approval for its Solia CSP S pacing lead for left bundle branch area pacing (LBBAP).

Biotronik is looking to get the FDA's approval for a line of MRI-safe pacemakers--courtesy of Biotronik The FDA approved a clinical trial of Biotronik's proMRI pacemaker, a device designed to operate ...

LAKE OSWEGO, Ore.- BIOTRONIK today announced the full commercial launch of the Acticor device family, including Acticor DX and CRT-DX devices. Leading electrophysiologists throughout the United States ...

BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...

Global manufacturer of cardiovascular medical devices BIOTRONIK announced the release of its Renamic product for the Japanese market. The announcement is in response to the dramatic growth of cardiac ...

LAKE OSWEGO, Oregon, BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration (FDA) granted approval for its Ilesto 7 implantable ...

Biotronik has received a CE mark for its bioresorbable scaffold. The device, intended for the treatment of coronary artery disease without using a permanent implant, is the first clinically proven ...

LAFAYETTE, Ind. − A Lafayette pain management clinic became the first in the nation to test a noninvasive device that stimulates the spinal cord to help with chronic pain. The Center for Pain ...